N Engl J Med. 2008 Apr 3;358(14):1427-9. doi: 10.1056/NEJMp0802107.

Regulating off-label drug use--rethinking the role of the FDA.

Source

Stanford Prevention Research Center, Program on Prevention Outcomes and Practices, Stanford University, Stanford, CA, USA.

PMID:: 18385495; [PubMed - indexed for MEDLINE]

Free full text

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Off-label or off-limits? [Nat Biotechnol. 2008]
Off-label or off-limits?
Ratner M, Gura T. Nat Biotechnol. 2008 Aug; 26(8):867-75.
FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration. [BETA. 1998]
FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.
Baker R. BETA. 1998 Jul; :8-9.
The First Amendment and FDA restrictions on off-label uses: the call for a new approach. [Food Drug Law J. 2008]
The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
Leghorn J, Brophy E, Rother P. Food Drug Law J. 2008; 63(2):391-406.
Review Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. [Pediatr Nurs. 2007]
Review Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
Novak E, Allen PJ. Pediatr Nurs. 2007 Jan-Feb; 33(1):64-70.
Review Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem. [J Contemp Health Law Policy. 2...]
Review Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
Teufel AT. J Contemp Health Law Policy. 2006 Spring; 22(2):383-408.

See reviews... See all...

Cited by 14 PubMed Central articles

Ten common questions (and their answers) about off-label drug use. [Mayo Clin Proc. 2012]
Ten common questions (and their answers) about off-label drug use.
Wittich CM, Burkle CM, Lanier WL. Mayo Clin Proc. 2012 Oct; 87(10):982-90. Epub 2012 Aug 6.
Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety. [Oncologist. 2012]
Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety.
Bonifazi M, Rossi M, Moja L, Scigliano VD, Franchi M, La Vecchia C, Zocchetti C, Negri E. Oncologist. 2012; 17(1):117-24. Epub 2011 Dec 30.
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. [Drug Healthc Patient Saf. 2011]
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia.
Lai LL, Tan MH, Lai YC. Drug Healthc Patient Saf. 2011; 3:27-36. Epub 2011 Jul 8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Regulating off-label drug use--rethinking the role of the FDA.
Regulating off-label drug use--rethinking the role of the FDA.
N Engl J Med. 2008 Apr 3 ;358(14):1427-9. doi: 10.1056/NEJMp0802107.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Regulating off-label drug use--rethinking the role of the FDA.

Source

MeSH Terms

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 14 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information